Detalhe da pesquisa
1.
Novel endoscopic scoring system for immune mediated colitis: A Multicenter Retrospective Study of 674 Patients.
Gastrointest Endosc;
2024 Jan 23.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38272276
2.
Association of prior local therapy and outcomes with programmed-death ligand-1 inhibitors in advanced urothelial cancer.
BJU Int;
130(5): 592-603, 2022 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34597472
3.
Antiproliferative Effect of Above-Label Doses of Somatostatin Analogs for the Management of Gastroenteropancreatic Neuroendocrine Tumors.
Neuroendocrinology;
111(7): 650-659, 2021.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32541155
4.
Optimal pathological response after neoadjuvant chemotherapy for muscle-invasive bladder cancer: results from a global, multicentre collaboration.
BJU Int;
128(5): 607-614, 2021 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33909949
5.
Immune checkpoint inhibitors in advanced upper and lower tract urothelial carcinoma: a comparison of outcomes.
BJU Int;
128(2): 196-205, 2021 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33556233
6.
Impact of performance status on treatment outcomes: A real-world study of advanced urothelial cancer treated with immune checkpoint inhibitors.
Cancer;
126(6): 1208-1216, 2020 03 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31829450
7.
Histological Subtypes and Response to PD-1/PD-L1 Blockade in Advanced Urothelial Cancer: A Retrospective Study.
J Urol;
204(1): 63-70, 2020 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31971495
8.
Prognostic Factors for Survival among Patients with Small Bowel Neuroendocrine Tumours Associated with Mesenteric Desmoplasia.
Neuroendocrinology;
106(4): 366-380, 2018.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29320779
9.
HLA-A*03 and response to immune checkpoint blockade in patients with cancer.
Lancet Oncol;
23(3): e99, 2022 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35240100
10.
Combination Systemic Therapies in Advanced Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs): A Comprehensive Review of Clinical Trials and Prospective Studies.
Biology (Basel);
12(8)2023 Jul 30.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37626955
11.
Development and validation of a prognostic nomogram for overall and disease-specific survival in patients with sarcomatoid urothelial carcinoma.
Urol Oncol;
41(6): 296.e17-296.e28, 2023 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36931981
12.
Treatment Rechallenge With Immune Checkpoint Inhibitors in Advanced Urothelial Carcinoma.
Clin Genitourin Cancer;
21(2): 286-294, 2023 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36481176
13.
Sarcomatoid Urothelial Carcinoma Is Associated With Limited Response to Neoadjuvant Chemotherapy and Poor Oncologic Outcomes After Radical Cystectomy.
Clin Genitourin Cancer;
21(4): 507.e1-507.e14, 2023 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37150667
14.
Response and Outcomes of Maintenance Avelumab After Platinum-Based Chemotherapy (PBC) in Patients With Advanced Urothelial Carcinoma (aUC): "Real World" Experience.
Clin Genitourin Cancer;
21(5): 584-593, 2023 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37414620
15.
Sarcomatoid Urothelial Carcinoma: A Population-Based Study of Clinicopathologic Characteristics and Survival Outcomes.
Clin Genitourin Cancer;
20(2): 139-147, 2022 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35101380
16.
Safety of Immunizations for the Adult Patient With Inflammatory Bowel Disease-A Systematic Review and Meta-analysis.
Inflamm Bowel Dis;
28(9): 1430-1442, 2022 09 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34849941
17.
ARID1A, BRG1, and INI1 deficiency in undifferentiated and dedifferentiated endometrial carcinoma: a clinicopathologic, immunohistochemical, and next-generation sequencing analysis of a case series from a single institution.
Hum Pathol;
130: 65-78, 2022 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36252860
18.
Outcomes of metastatic urothelial carcinoma following discontinuation of enfortumab-vedotin.
Clin Genitourin Cancer;
20(1): 11-16, 2022 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34503934
19.
Association of the Time to Immune Checkpoint Inhibitor (ICI) Initiation and Outcomes With Second Line ICI in Patients With Advanced Urothelial Carcinoma.
Clin Genitourin Cancer;
20(6): 558-567, 2022 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36155169
20.
Response and Outcomes to Immune Checkpoint Inhibitors in Advanced Urothelial Cancer Based on Prior Intravesical Bacillus Calmette-Guerin.
Clin Genitourin Cancer;
20(2): 165-175, 2022 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35078711